Celrixafor Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Celrixafor Injection contains plerixafor, a haematopoietic stem cell mobiliser. Its labelling describes it for use in autologous stem cell transplant, where blood-forming stem cells are collected from a patient and returned to the body after chemotherapy or radiation. It is described as causing specific blood cells to move from the bone marrow into the bloodstream so they can be collected for transplant. It is given by a professional doctor or nurse, who decides the dosage, duration, and interval after assessing the disease.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for use in autologous stem cell transplant
- Described as mobilising blood-forming stem cells from the bone marrow into the bloodstream for collection
- Described as helping remove the cells for transplant after chemotherapy or radiation
Described Dosage & Administration
- Given only by a professional doctor or nurse; it should not be self-administered
- The dosage, duration, and interval are decided by the doctor after assessing the disease
- Benefits can take weeks or even months to be felt
Described Side Effects
Commonly described side effects include:
- Injection site reaction
- Nausea
- Diarrhoea
These are described as commonly temporary. The doctor should be consulted if they persist for longer.
Precautions
- A complete medical history and list of current medicines should be shared
- Not recommended during pregnancy or breastfeeding; the doctor should be informed
- Effective contraception should be used regardless of gender
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains plerixafor and is used in autologous stem cell transplant, to mobilise blood-forming stem cells from the bone marrow into the bloodstream for collection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as given only by a professional doctor or nurse, who decides the dosage, duration, and interval after assessing the disease.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.